首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Mechanisms of Core Chinese Herbs against Colorectal Cancer: A Study Based on Data Mining and Network Pharmacology
【24h】

Mechanisms of Core Chinese Herbs against Colorectal Cancer: A Study Based on Data Mining and Network Pharmacology

机译:核心中草药对整体癌症的机制:基于数据挖掘和网络药理学的研究

获取原文
           

摘要

Colorectal cancer (CRC) is now the second most deadly cancer globally. Chinese herbal medicine (CHM) plays an indispensable role in CRC treatment in China. However, the core herbs (the CHs) in the treatment of CRC and their underlying therapeutic mechanisms remain unclear. This study aims to uncovering the CHs and their mechanisms of action of CRC treatment, applying data mining and network pharmacology approach. First, CHM prescriptions treating CRC were collected from clinical studies from the Chinese National Knowledge Infrastructure (CNKI) and MEDLINE databases, and the CHs were identified through data mining. Then, the bioactive compounds and the corresponding putative targets of the CHs were obtained from three traditional Chinese medicine (TCM) databases. CRC related targets were acquired from three disease databases; the overlapping targets between the CHs and CRC were identified as the therapeutic targets. Subsequently, functional enrichment analysis was performed to elucidate the mechanisms of the CHs on CRC. Moreover, networks were constructed to screen the major bioactive compounds and therapeutic targets. Finally, prognostic values of the major target genes were evaluated by survival analysis, and molecular docking simulation was performed to assess the binding affinity of key targets and major bioactive compounds. It came out that 10 the CHs from 113 prescriptions and 190 bioactive compounds with 118 therapeutic targets were identified. The therapeutic targets were mainly enriched in the biological progress of transcription, apoptosis, and response to cytokine. Various cancer-associated signaling pathways, including microRNAs, TNF, apoptosis, PI3K-Akt, and p53, were involved. Furthermore, 15 major bioactive compounds and five key target genes (VEGFA, CASP3, MYC, CYP1Y1, and NFKB1) with prognostic significance were identified. Additionally, most major bioactive compounds might bind firmly to the key target proteins. This study provided an overview of the anti-CRC mechanisms of the CHs, which might refer to the regulation of apoptosis, transcription, and inflammation.
机译:直肠癌(CRC)现在是全球第二次致命癌症。中草药(CHM)在中国的CRC治疗中起着不可或缺的作用。然而,核心草药(CHS)治疗CRC及其潜在的治疗机制仍不清楚。本研究旨在揭示CHS及其CRC处理的作用机制,应用数据挖掘和网络药理学方法。首先,从中国国家知识基础设施(CNKI)和MEDLINE数据库的临床研究中收集处理CRC的CHM处方,通过数据挖掘确定了CHS。然后,从三种中药(TCM)数据库中获得CHS的生物活性化合物和相应推定靶标。 CRC相关靶标是从三种疾病数据库中获得的; CHS和CRC之间的重叠靶标被鉴定为治疗靶标。随后,进行功能性富集分析以阐明CHS对CRC的机制。此外,构建网络以筛选主要的生物活性化合物和治疗靶标。最后,通过存活分析评估主要靶基因的预后值,进行分子对接模拟以评估关键靶标和主要生物活性化合物的结合亲和力。它出现了来自113个处方和190个具有118个治疗靶标的190种生物活性化合物的CH。治疗靶标主要富集在转录,细胞凋亡和对细胞因子的反应中。涉及各种癌症相关的信号传导途径,包括MicroRNA,TNF,凋亡,PI3K-AKT和P53。此外,鉴定了15种主要的生物活性化合物和五个关键靶基因(VEGFA,CASP3,MYC,CYP1Y1和NFKB1),具有预后意义。此外,大多数主要生物活性化合物可能牢固地与关键目标蛋白质结合。本研究提供了CHS的抗CRC机制的概述,这可能是指细胞凋亡,转录和炎症的调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号